Topiroxostat Completed Phase 2 Trials for Hyperuricemia Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science2
clinicaltrials.gov IdentifierTitleDrugs
NCT02837198Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)